Compound and technology requests

About this program

Bristol Myers Squibb offers investigator‑sponsored access to select preclinical compounds and research technologies/materials (e.g., cell lines, transgenic animals, nucleic acid constructs, purified proteins, engineered bacteria/viruses) for laboratory and animal studies across therapeutic areas including oncology, cardiovascular, immunoscience, fibrosis and neuroscience. Applicants must register/login to the BMS application portal, accept the Terms & Conditions and Privacy Policy, complete demographic fields and upload required documents as PDF files. Compound requests require a Letter of Intent (LOI) and CV; technology/materials requests require a Research Proposal and CV, and transgenic animal requests also require a completed animal welfare risk assessment; templates and guidance are provided on the portal.